Immunoassay Reagent QMS® Amikacin CLIA Non-Waived For Automated Clinical Chemistry Analyzers 172 Tests

Features

• The QMS Amikacin assay is intended for the quantitative determination of amikacin in human serum or plasma on automated clinical chemistry analyzers
• Significantly reduces labor, time, and expense compared to HPLC or LCMS and other technologies
• Based on competitive inhibition immunoassay principle whereby free-drug in the sample competes for antibody binding sites with drug molecules coated onto uniform microparticles
• Liquid stable and ready-to-use
• Applicable to general chemistry analyzers
• Validated parameters assure lab-to-lab reproducibility
• Excellent correlation to reference methods
• Optimal sensitivity, precision and dynamic range
• Low cross-reactivity with metabolites and commonly co-administered drugs
• Low interference from endogenous substances

More Information

• SDS